Kenneth Newell, MD
Surgery · Atlanta, GANPI 1447292529
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $30,459 of the $49,513 with a category attached, or 61.5%. 9 manufacturers reported payments, led by CSL Behring at 40.0% of the total. Reporting peaked in 2019 at $23,493 and has fallen 99.6% since, to $90 in 2025. Among surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $1904.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$20K
- Mallinckrodt Hospital Products Inc.$11K
- Mallinckrodt Enterprises LLC$7K
- Sanofi-aventis U.S. LLC$5K
- Takeda Pharmaceuticals U.S.A., Inc.$4K
- Immucor, Inc.$2K
- plus $1K from 3 others
What the payments were for
- Consulting fees$30,45962%
- Speaking & faculty fees$14,03728%
- Travel & lodging$4,3869%
- Food & beverage$6311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 11 | $19,809 |
| Mallinckrodt Hospital Products Inc. | 1 | $10,500 |
| Mallinckrodt Enterprises LLC | 2 | $6,892 |
| Sanofi-aventis U.S. LLC | 3 | $4,820 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $4,200 |
| Immucor, Inc. | 1 | $1,900 |
| Merck | 1 | $1,045 |
| Veloxis Pharmaceuticals, Inc. | 4 | $256 |
| Kamada Ltd. | 1 | $90 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$49,513 in reported general payments places this provider in the 95th percentile of 855 surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 100 | $15,690 |
| Humalog Kwikpen U-100Insulin Lispro | 16 | $2,078 |
| Nifedipine ErNifedipine | 47 | $1,093 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 19 | $1,087 |
| Novolog FlexpenInsulin Aspart | 12 | $1,020 |
| Mycophenolate Mofetil | 11 | $809 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 176 | $491 |
| Prednisone | 108 | $296 |
| Atorvastatin Calcium | 127 | $253 |
| Carvedilol | 37 | $126 |
| Pantoprazole Sodium | 28 | $105 |
| Clonidine Hcl | 14 | $52 |
| Rosuvastatin Calcium | 18 | $49 |
Paid to pharmacies, not to this prescriber.
Other surgery in Atlanta
- Kendra GrubbAtlanta$374K
- Ankit PatelAtlanta$217K
- Kevin NguyenAtlanta$161K
- Nathaniel LytleAtlanta$118K
- David ParkAtlanta$112K
- Dominic PapandriaAtlanta$60K
- Marwan KazimiAtlanta$33K
- Charles ProcterAtlanta$27K
- Vishwanath DanthuluriAtlanta$27K
- Idelberto BadellAtlanta$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.